Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Radiosynthesis and microPET evaluation of F-18 CRF1 receptor PET tracer presented

June 18, 2014

Phase I results for the rituximab biosimilar PF-05280586

June 18, 2014

CKD-L, an HDAC6 inhibitor, may have potential for the treatment of RA

June 18, 2014

Rheumatoid arthritis candidate BI-638683 well tolerated in phase I study

June 18, 2014

Novel PIKfyve inhibitor described by Astellas scientists

June 17, 2014

PSMA ligand evaluated in patients for the diagnosis of prostate cancer

June 17, 2014

[18F]-GP1: a potential a PET tracer for thrombi in humans

June 17, 2014

Update on phase I trial of AG-221, a potent IDH2 mutant protein inhibitor

June 17, 2014

Novel antiviral drugs demonstrate efficacy against diverse RNA and DNA viral pathogens

June 17, 2014

Phase I results on OPB-51602 in relapsed/refractory hematological malignancies

June 16, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...